| Structure | Chemical Name | CAS | MF |
|
Formamide, N-(3-ethyltricyclo[3.3.1.13,7]dec-1-yl)- (9CI)
|
415701-59-6
|
C13H21NO
|
|
[1-(4-Fluoro-benzyl)-piperidin-2-yl]-methanol
|
415701-69-8
|
C13H18FNO
|
|
[1-(2-Methyl-benzyl)-piperidin-2-yl]-Methanol
|
415701-94-9
|
C14H21NO
|
|
[1-(3-Chloro-benzyl)-piperidin-2-yl]-methanol
|
415702-06-6
|
C13H18ClNO
|
|
Benzothiazole, 2-(2-methoxyethoxy)- (9CI)
|
415702-31-7
|
C10H11NO2S
|
|
N-(3-chloro-4-fluorophenyl)-2-[(5-nitro-1H-benzimidazol-2-yl)sulfanyl]acetamide
|
415702-38-4
|
C15H10ClFN4O3S
|
|
4,6(1H,5H)-Pyrimidinedione,5-ethyldihydro-1-(2-propenyl)-2-thioxo-(9CI)
|
415702-86-2
|
C9H12N2O2S
|
|
D-erythro-Pentofuranoside, methyl 3-deoxy- (9CI)
|
415704-37-9
|
C6H12O4
|
|
Ribavirin Impurity R
|
415704-39-1
|
C11H16O7
|
|
5-FLUORO-1-(β-L-RIBOFURANOSYL)CYTOSINE (4-AMINO-5-FLUORO-1-β-L-RIBOFURANOSYLPYRIMIDINONE)
|
415704-64-2
|
C9H12FN3O5
|
|
5-FLUORO-4-THIOXO-1-(β-L-RIBOFURANOSYL)URACIL
|
415705-21-4
|
C9H11FN2O5S
|
|
9-(β-L-RIBOFURANOSYL)-6-CHLOROPURINE
|
415705-32-7
|
C10H11ClN4O4
|
|
3aH-Inden-3a-ol, 1,2,3,6-tetrahydro-6-methyl-, (3aS,6S)- (9CI)
|
415707-86-7
|
C10H14O
|
|
3aH-Inden-3a-ol, 1,2,3,4-tetrahydro-4-methyl-, (3aS,4R)- (9CI)
|
415707-87-8
|
C10H14O
|
|
4,7-Methano-1H-benzotriazole,1-butyl-3a,4,5,6,7,7a-hexahydro-,(3aR,4S,7R,7aS)-rel-(9CI)
|
415708-17-7
|
C11H19N3
|
|
3H-Pyrrolo[1,2-c][1,2,3]triazole,3a,4,5,6-tetrahydro-6-methyl-,(3aR,6S)-rel-(9CI)
|
415708-32-6
|
C6H11N3
|
|
3H-Pyrrolo[1,2-c][1,2,3]triazole,3a,4,5,6-tetrahydro-6-methyl-,(3aR,6R)-rel-(9CI)
|
415708-33-7
|
C6H11N3
|
|
Benzothiazole, 2-(2-ethoxyethoxy)- (9CI)
|
415711-51-2
|
C11H13NO2S
|
|
CHEMBRDG-BB 5347228
|
415711-83-0
|
C9H12ClN3O
|
|
[1-(2,4-Dichloro-benzyl)-piperidin-2-yl]-methanol
|
415712-00-4
|
C13H17Cl2NO
|
|
methyl 3-(piperidin-1-ylsulfonyl)benzoate
|
415712-10-6
|
C13H17NO4S
|
|
[1-(2-Fluoro-benzyl)-piperidin-2-yl]-methanol
|
415712-70-8
|
C13H18FNO
|
|
3-[(4-methylpiperidin-1-yl)sulfonyl]benzoic acid
|
415712-97-9
|
C13H17NO4S
|
|
RI-1
|
415713-60-9
|
C14H11Cl3N2O3
|
|
2-(4-([4-(Propan-2-yl)phenyl]methyl)piperazin-1-yl)ethan-1-ol
|
415714-03-3
|
C16H26N2O
|
|
[1-(3-Chloro-benzyl)-piperidin-3-yl]-methanol
|
415714-07-7
|
C13H18ClNO
|
|
4(3H)-Pyrimidinone,3-ethyl-2-(ethylthio)-6-hydroxy-(9CI)
|
415714-24-8
|
C8H12N2O2S
|
|
4(3H)-Pyrimidinone,3-ethyl-6-hydroxy-2-(2-propenylthio)-(9CI)
|
415714-54-4
|
C9H12N2O2S
|
|
ethyl [(4-iodo-2-methylphenyl)amino]acetate
|
415715-69-4
|
C11H14INO2
|
|
[1-(2-Fluoro-benzyl)-piperidin-3-yl]-methanol
|
415716-07-3
|
C13H18FNO
|
|
[1-(2-Methyl-benzyl)-piperidin-3-yl]-Methanol
|
415716-13-1
|
C14H21NO
|
|
4-(5-BROMOTHIOPHEN-2-YL)BENZONITRILE
|
415718-60-4
|
C11H6BrNS
|
|
[1-(4-Chloro-benzyl)-piperidin-2-yl]-methanol
|
415720-36-4
|
C13H18ClNO
|
|
2-(4-(2-broMobenzyl)piperazin-1-yl)ethanol
|
415721-00-5
|
C13H19BrN2O
|
|
[1-(2-Chloro-benzyl)-piperidin-3-yl]-methanol
|
415721-15-2
|
C13H18ClNO
|
|
2-[4-(4-Bromobenzyl)piperazin-1-yl]ethanol
|
415721-83-4
|
C13H19BrN2O
|
|
[1-(4-Methyl-benzyl)-piperidin-3-yl]-Methanol
|
415722-06-4
|
C14H21NO
|
|
1,3,5-Triazatetracyclo[3.3.1.03,9.07,9]nonane(9CI)
|
415722-62-2
|
C6H9N3
|
|
1-(3-chlorobenzyl)piperidine-3-carbohydrazide
|
415723-29-4
|
C13H18ClN3O
|
|
1,1'-[1,3-Propanediylbis(oxy)]bis[2,5-dimethylbenzene]
|
415724-02-6
|
C19H24O2
|
|
4-(3-(2-broMophenoxy)propyl)Morpholine
|
415724-40-2
|
C13H18BrNO2
|
|
1H-Pyrazole, 4-[3-(4-fluorophenoxy)propyl]-3,5-dimethyl-
|
415724-43-5
|
C14H17FN2O
|
|
Poricoic acid G
|
415724-84-4
|
C30H46O5
|
|
9-Methyl Biotin (Mixture of diastereoMers)
|
415725-35-8
|
C11H18N2O3S
|
|
4H-Inden-1-amine,3-ethoxy-5,6,7,7a-tetrahydro-N,N-dimethyl-(9CI)
|
415725-52-9
|
C13H21NO
|
|
1-PHENYLVINYLBORONIC ACID, PROPANEDIOL CYCLIC ESTER
|
415727-02-5
|
C11H13BO2
|
|
1-Aza-3-silacyclopentane-5-carboxylicacid,3,3-dimethyl-,(5R)-(9CI)
|
415898-69-0
|
C6H13NO2Si
|
|
5-cyclopropylisoxazole
|
415898-82-7
|
C6H7NO
|
|
5-Hepten-2-one, 3-hydroxy- (9CI)
|
415899-62-6
|
C7H12O2
|
|
5-Hepten-2-one, 3-hydroxy-, (5Z)- (9CI)
|
415899-63-7
|
C7H12O2
|
|
5-Hepten-2-one, 3-hydroxy-6-methyl-, (3S)- (9CI)
|
415899-70-6
|
C8H14O2
|
|
5-Hepten-2-one, 3-hydroxy-, (3S,5E)- (9CI)
|
415899-71-7
|
C7H12O2
|
|
5-Hepten-2-one, 3-hydroxy-, (3S,5Z)- (9CI)
|
415899-72-8
|
C7H12O2
|
|
4-Heptyn-2-one, 3-hydroxy-, (3S)- (9CI)
|
415899-74-0
|
C7H10O2
|
|
Grapiprant
|
415903-37-6
|
C26H29N5O3S
|
|
3-Bromo-6-chloro-2,5-dimethyl-4-nitropyridine ,97%
|
415907-79-8
|
C7H6BrClN2O2
|
|
Methyl 2-(2-Methyl-4-nitrophenyl)acetate
|
415912-62-8
|
C9H9NO4
|
|
2-Pyridineacetonitrile,4-amino-(9CI)
|
415912-70-8
|
C7H7N3
|
|
2-(5-aMinopyridin-2-yl)acetic acid
|
415912-76-4
|
C7H8N2O2
|
|
Ethyl 2-(6-nitropyridin-3-yl)acetate
|
415912-99-1
|
C9H10N2O4
|
|
quinoline-5-sulfonamide
|
415913-05-2
|
C9H8N2O2S
|
|
1H-Imidazole-4-sulfonamide,1,2-dimethyl-(9CI)
|
415913-06-3
|
C5H9N3O2S
|
|
TRANS-1-ETHOXY-4-(4-ETHYL-CYCLOHEXYL)-2,3-DIFLUORO-BENZENE
|
415915-41-2
|
C16H22F2O
|
|
TRANS-1-(4-BUTYL-CYCLOHEXYL)-4-ETHOXY-2,3-DIFLUORO-BENZENE
|
415915-42-3
|
|
|
1H-INDOLE-3-CARBOXYLIC ACID,6-(TRIFLUOROMETHYL)-,METHYL ESTER
|
415918-12-6
|
C11H8F3NO2
|
|
(S)-(+)-(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A:3,4-A']DINAPHTHALEN-4-YL)BIS[(1R)-1-PHENYLETHYL]AMINE,DICHLOROMETHANE ADDUCT
|
415918-91-1
|
C36H30NO2P
|
|
2-(1,1-DIOXO-TETRAHYDRO-1LAMBDA6-THIOPHEN-3-YLAMINO)-3-(4-HYDROXY-PHENYL)-PROPIONIC ACID
|
415919-39-0
|
C13H17NO5S
|
|
2H-Indeno[5,4-d]isoxazole(9CI)
|
415920-76-2
|
C10H7NO
|
|
5-HEPTYL-2-FURANTHIOL
|
415921-25-4
|
C11H18OS
|
|
1,7-Dioxaspiro[5.5]undecane-3,4-diol, 9-ethyl-, (3R,4S,6S,9S)- (9CI)
|
415921-39-0
|
C11H20O4
|
|
1,7-Dioxaspiro[5.5]undecane-3,4-diol, 9-ethyl-, (3R,4S,6R,9S)- (9CI)
|
415921-40-3
|
C11H20O4
|
|
[1-(2,6-Dichloro-benzyl)-piperidin-2-yl]-methanol
|
415924-36-6
|
C13H17Cl2NO
|
|
Piperazine, 1-(cyclohexylmethyl)-4-ethyl- (9CI)
|
415924-99-1
|
C13H26N2
|
|
1-(4-(4-((Pyridin-2-yl)methyl)piperazin-1-yl)phenyl)ethanone
|
415925-40-5
|
C18H21N3O
|
|
Piperazine, 1-ethyl-4-[(5-methyl-2-furanyl)methyl]- (9CI)
|
415925-67-6
|
C12H20N2O
|
|
(7alpha,17beta)-17-(Acetyloxy)-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]estr-4-en-3-one
|
415927-29-6
|
C34H51F5O3S
|
|
L-Alanine, 3-butenyl ester (9CI)
|
415928-83-5
|
C7H13NO2
|
|
1-[(3-NITROPHENYL)METHYL]PYRROLIDINE
|
415931-07-6
|
C11H14N2O2
|
|
2,4-Diiodo-6-{[methyl(1-methylpiperidin-4-yl)-amino]methyl}phenol
|
415932-24-0
|
C14H20I2N2O
|
|
1-(4-fluorobenzyl)piperidine-3-carbohydrazide
|
415934-95-1
|
C13H18FN3O
|
|
Furan, 4-ethyltetrahydro-2-(4-methoxyphenyl)- (9CI)
|
415936-10-6
|
C13H18O2
|
|
3-Piperidinecarboxylicacid,1-(2-furanylmethyl)-,hydrazide(9CI)
|
415937-00-7
|
C11H17N3O2
|
|
3-Piperidinecarboxylicacid,1-(3-thienylmethyl)-,hydrazide(9CI)
|
415937-73-4
|
C11H17N3OS
|
|
1H-Pyrazole, 3,5-dimethyl-4-(5-phenoxypentyl)-
|
415938-68-0
|
C16H22N2O
|
|
CYCLOHEXYLDI(1-ADAMANTYL)PHOSPHINE
|
415941-50-3
|
C26H41P
|
|
Di-tert-butyl(2-dimethylaminophenyl)phosphine
|
415941-58-1
|
C16H28NP
|
|
N-(3-Chloro-4-Methoxyphenyl)-2-fluorobenzaMide, 97%
|
415943-80-5
|
C14H11ClFNO2
|
|
5-(4-METHOXY-2-NITROPHENYL)-2-FURALDEHYDE
|
415943-88-3
|
C12H9NO5
|
|
Benzoic acid, 3-acetyl-2,6-dihydroxy-5-methyl- (9CI)
|
415945-15-2
|
C10H10O5
|
|
methyl 4-[(4-hydroxypiperidin-1-yl)methyl]benzoate
|
415946-11-1
|
C14H19NO3
|
|
N-[(2-fluorophenyl)methyl]-1-methylpiperidin-4-amine
|
415946-43-9
|
C13H19FN2
|
|
1-(4-chlorobenzyl)pyrrolidin-3-ol
|
415946-61-1
|
C11H14ClNO
|
|
1-acetyl-N-cycloheptylpiperidin-4-amine
|
415947-24-9
|
C14H26N2O
|
|
Ethanol, 2,2-[(4-ethylcyclohexyl)imino]bis- (9CI)
|
415948-31-1
|
C12H25NO2
|
|
Ethanol, 2-[(4-ethylcyclohexyl)propylamino]- (9CI)
|
415951-02-9
|
C13H27NO
|
|
1-acetyl-N-(4-methoxybenzyl)piperidin-4-amine
|
415951-99-4
|
C15H22N2O2
|
|
Piperazine, 1-(4-ethylcyclohexyl)-4-methyl- (9CI)
|
415952-60-2
|
C13H26N2
|
|
1-(3,4-dichlorobenzyl)pyrrolidin-3-ol
|
415953-24-1
|
C11H13Cl2NO
|
|
1,2-Ethanediamine,N-(4-ethylcyclohexyl)-N,N,N-trimethyl-(9CI)
|
415953-91-2
|
C13H28N2
|
|
methyl 4-[(4-methylpiperidin-1-yl)methyl]benzoate
|
415954-49-3
|
C15H21NO2
|